lodenafil
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
2
Earliest trial started Nov 1, 2008 (NCT00817830)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Phosphodiesterase 5AINHIBITOR
PDE5A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bis-(2-(4-(4-ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1h-pyrazolo(4,3-d)pyrimidin-5-yl)-benzenesulfonyl)piperazin-1-yl)-ethyl)carbonate
- lodenafil carbonate
- lodenafil carbonate
- lodenafil carbonate
- lodenafil carbonate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01180283 | Phase 4 | Jan 1, 2009 | Cristália Produtos Químicos Farmacêuticos Ltda. |
| NCT00817830 | Phase 4 | Nov 1, 2008 | Cristália Produtos Químicos Farmacêuticos Ltda. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cristália Produtos Químicos Farmacêuticos Ltda. | For profit | 2 | 2 | 1 | 2008 |
1 organizations
Page 1 / 1